CrushSCI.com
109.9平均天数
111中位天数
54最短天数
187最长天数
5752025发文量

Paper Review Records

全部论文审稿周期

15 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

86 天

Preclinical evaluation of a CD137-targeted PET tracer for detection of inflammatory arthritis

作者
Luna Ge; Shuxian Zhou; Binbin Ding; Mengjie Bai; Yuang Zhang; Jihong Pan; Lin Wang; Yongpeng Ge; Kai Cheng展开收起
作者单位
Biomedical Sciences College and Shandong Medicinal Biotechnology Centre, Key lab for Biotech-Drugs of National Health Commission, Key Lab for Genetic Engineering and Synthetic Biology of Shandong Province, Ji'nan, 250117, China; Neck, Shoulder, Waist and Leg Pain Hospital of Shandong First Medical University, Ji'nan, Shandong, 250117, China; Department of Rheumatology, China-Japan Friendship Hospital, Beijing, 100029, China; Center for Nuclear Medicine and Molecular Imaging, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, 250117, China展开收起
PDF源文件 DOI 网页
70 天

Integrated [68Ga]Ga-FAPI-7ND PET/CT and stromal profiling of immunocompetent syngeneic tumor models for FAP-targeted radionuclide therapy

作者
Huijie Li; Yuling Zhang; Xin Ren; Chenyue Liu; Lexing Zhang; Yuanbo Wang; Wei Qiang; Shuai Jiao; Qianqian Geng; Rui Gao展开收起
作者单位
Department of Nuclear Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, 277W Yanta Road, Xi'an, Shaanxi, 710061, China展开收起
PDF源文件 DOI 网页
54 天

cGMP production of radiometal solutions from solid targets at a university-scale facility

作者
Aidan Bender; Brock Mower; Brandon Buckway; Jeffrey Yap展开收起
作者单位
Center for Quantitative Cancer Imaging and Therapy, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, 84112, USA; Department of Molecular Pharmaceutics, University of Utah, Salt Lake City, UT, 84112, USA; Sego Therapeutics, Salt Lake City, UT, 84102, USA; Department of Radiology and Imaging Science, University of Utah, Salt Lake City, UT, 84112, USA展开收起
PDF源文件 DOI 网页
112 天

FAP-targeted [177Lu]Lu-FAP-2286 radioligand therapy synergizes with the STING agonist diABZI to enhance antitumor immunity in lung cancer

作者
Jiahao Xie; Yijin Zou; Dazhi Shi; Yuhao Huang; Wenlan Zhou; Ying Tian; Meng Wang; Pei Han; Hubing Wu; Lijuan Wang展开收起
作者单位
Department of Nuclear Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong Province, China; Department of Nuclear Medicine, Guangzhou Universal Medical Imaging Diagnostic Center, Guangzhou City, Guangdong Province, China展开收起
PDF源文件 DOI 网页
65 天

Exploration of the cysteine protease trapping approach to prolong tumor retention of antifolate targeted radionuclide therapeutics

作者
Sadie Klein; Audifás-Salvador Matus-Meza; Julian M. Klein; Pedram Rikhtechi; Katie Brake; Daniel Carlson; Kiana Sherkat Sadi; Erika A. Cone; Tobin Shea; Jered C. Garrison展开收起
作者单位
Eppley Institute for Research in Cancer and Allied Diseases, University of Nebraska Medical Center, Omaha, NE, 68105, United States; Department of Pharmaceutical Sciences, University of Nebraska Medical Center, Omaha, NE, 68105, United States; Department of Biochemistry and Molecular Biology, University of Nebraska Medical Center, Omaha, NE, 68105, United States; Department of Biomedical Science, Creighton University, Omaha, NE, 68178, United States; Center for Drug Delivery and Nanomedicine, University of Nebraska Medical Center, Omaha, NE, 68105, United States展开收起
PDF源文件 DOI 网页
187 天

Translational imaging evidence for rapid reversal of amyloid and myelin pathology following deep cervical lymphatic–venous anastomosis in Alzheimer's disease

作者
Xu Wang; Yongtao Liu; Jinxiang Liu; Rongyi Wang; Jing Zheng; Zhiyang Deng; Kunxiu Song; Daijie Zhang; Chunwei Wang; Kai Zhu; Jinming Zhang; Chunying Wu; Guige Hou; Erik F.J. de Vries; Yanming Wang展开收起
作者单位
Institute of Nuclear Medicine and Molecular Imaging, Shandong Medical and Pharmaceutical University Hospital, Binzhou, 256603, China; Department of Nuclear Medicine, Shandong Medical and Pharmaceutical University Hospital, Binzhou, 256603, China; Department of Microsurgery, Shandong Medical and Pharmaceutical University Hospital, Binzhou, 256603, China; Department of Nuclear Medicine, PLA General Hospital, Beijing, 100039, China; School of Medicine, Case Western Reserve University, Cleveland, OH, 44106, USA; School of Pharmacy, Shandong Medical and Pharmaceutical University, Yantai, 264003, China; Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands; Binzhou Institute of Technology, Weiqiao-UCAS Science and Technology Park, Binzhou, China展开收起
PDF源文件 DOI 网页

FAQ

NUCLEAR MEDICINE AND BIOLOGY审稿要多久?

截至2026-11-19,CrushSCI 收录了 NUCLEAR MEDICINE AND BIOLOGY 的 15 篇完整审稿记录。最快一篇从收稿到录用用了 54 天(cGMP production of radiometal solutions from solid targets at a university-scale facility,2026-08-13 收稿,2026-10-06 录用),最慢一篇用了 187 天;平均 109.9 天,中位数 111 天。

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

我们会在半小时内回复。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿59.6 天

中位数65 天

Contact CrushSCI

联系 CrushSCI

留下手机号或微信号,我们将与你确认学术润色、结构优化或一对一辅导咨询需求。

我们会在半小时内回复。

当前选择:学术咨询服务

预留联系方式

也可以直接发送邮件至 leader@crushsci.com

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。